PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Estimated Vaccine Effectiveness and Durability of Pfizer/BioNTech 2024-2025 COVID-19 Vaccine
- Conditions
- COVID-19
- Interventions
- Biological: Pfizer-BioNTech BNT162b2 COVID-19 VaccinatedBiological: Not vaccinated with 2024-2025 formulated COVID-19 vaccine
- First Posted Date
- 2024-11-25
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1
- Registration Number
- NCT06703190
- Locations
- 🇺🇸
Pfizer, New York, New York, United States
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
- First Posted Date
- 2024-11-21
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 211
- Registration Number
- NCT06698796
- Locations
- 🇧🇬
Medical Center Artmed, Plovdiv, Bulgaria
🇺🇸Rheumatology & Pulmonary Clinic, Beckley, West Virginia, United States
🇨🇳Beijing Peking Union Medical College Hospital, Beijing, Beijing, China
A Study to Learn About if the Study Medicine Called Ibuzatrelvir Changes How the Body Process the Other Medicine Dabigatran Etexilate in Healthy Adults
- Conditions
- SARS-CoV-2 Infections
- Interventions
- Drug: Treatment BDrug: Treatment A
- First Posted Date
- 2024-11-18
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 20
- Registration Number
- NCT06693518
- Locations
- 🇧🇪
Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Région DE, Belgium
A Study to Learn How Different Amounts of the Study Medicine Called PF-08049820 Are Tolerated and Act in the Body in Healthy Adults
- First Posted Date
- 2024-11-13
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 53
- Registration Number
- NCT06686797
- Locations
- 🇺🇸
Pfizer Clinical Research Unit - New Haven, New Haven, Connecticut, United States
Comparison of Patient-reported Outcomes for Rimegepant and Triptans in the 2023 US National Health and Wellness Survey
- Conditions
- Migraine
- First Posted Date
- 2024-11-08
- Last Posted Date
- 2024-12-31
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1363
- Registration Number
- NCT06680206
- Locations
- 🇺🇸
Pfizer, New York, New York, United States
A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer (NSCLC) Which Has Spread Out.
- First Posted Date
- 2024-11-07
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1
- Registration Number
- NCT06678555
- Locations
- 🇨🇳
Pfizer, Taipei, Taiwan
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Conditions
- COVID-19 SARS-CoV-2 Infection
- Interventions
- Drug: placebo
- First Posted Date
- 2024-11-07
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 2330
- Registration Number
- NCT06679140
- Locations
- 🇺🇸
Applied Research Center of Arkansas, Little Rock, Arkansas, United States
🇺🇸National Institute of Clinical Research - Bakersfield, Bakersfield, California, United States
🇺🇸310 Clinical Research, Inglewood, California, United States
A Study to Learn More About the Study Medicine PF-07275315 in Healthy Chinese Adult Participants
- First Posted Date
- 2024-11-05
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 13
- Registration Number
- NCT06675188
- Locations
- 🇨🇳
Huashan Hospital,Fudan University, Shanghai, Shanghai, China
A Study to Learn About the Study Medicine Called PF-07905428 in Healthy Participants and Participants With Acne Vulgaris
- First Posted Date
- 2024-11-04
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 52
- Registration Number
- NCT06671834
- Locations
- 🇨🇦
Innovaderm Research Inc., Montréal, Quebec, Canada
A Study to Learn How Different Forms of the Study Medicine Called PF-07976016 Are Taken Up Into the Blood in Healthy Adults
- Conditions
- Healthy Volunteers
- Interventions
- Drug: PF-07976016 Formulation ADrug: PF-07976016 Formulation B
- First Posted Date
- 2024-11-01
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT06670170
- Locations
- 🇺🇸
Pfizer Clinical Research Unit - New Haven, New Haven, Connecticut, United States